循环瘤DNA (ctDNA) 及其在妇科恶性瘤中的作用
Tali Pomerantz1, Rebecca Brooks2
1University of California Davis Medical Center, 4860 Y Street, Suite 2500, Sacramento, CA, 95817, USA. tspomerantz@ucdavis.edu.
Current treatment options in oncology
|March 13, 2024
概括
从液体活检中循环瘤DNA (ctDNA) 提供了一种不那么侵入性的癌症检测方法. 然而,它在妇科癌症中的应用需要更多的研究来进行常规的临床使用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环瘤DNA (ctDNA) 是体液中发现的癌细胞的DNA片段.
- 液体活检,通常使用血液或血,是获得ctDNA的最小侵入性方法.
- ctDNA分析检测突变,副本数量改变,基因融合和甲基化,以获得癌症洞察力.
研究的目的:
- 审查ctDNA在癌症治疗中的潜在应用.
- 与其他癌症相比,强调ctDNA在妇科恶性瘤中的目前有限的使用.
- 强调需要对卵巢,子宫内膜和子宫癌进行进一步的研究.
主要方法:
- 使用聚合酶链反应 (PCR) 或下一代测序 (NGS) 检测ctDNA.
- 对ctDNA进行各种遗传变异和表观遗传修饰的分析.
- 在妇科癌症与其他固体瘤中ctDNA功效的比较.
主要成果:
- ctDNA分析对癌症诊断,预后,向治疗和监测治疗反应具有前景.
- ctDNA为组织活检提供了一个不那么侵入性的替代方案,使得序列监测成为可能.
- 在妇科瘤学中采用ctDNA落后于其他癌症类型,只有有限的专门研究.
结论:
- 通过早期检测和个性化治疗策略,ctDNA具有改善癌症护理的巨大潜力.
- 进一步的临床验证和研究对于将ctDNA纳入妇科癌症的常规管理至关重要.
- 在卵巢,子宫内膜和子宫癌中扩大ctDNA应用可能会显著有利于患者的治疗结果.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K


